Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic
Status:
Completed
Trial end date:
2018-12-31
Target enrollment:
Participant gender:
Summary
This study assesses the effectiveness of targeted active case detection among high-risk
populations in Southern Lao Peoples Democratic Republic (PDR). The investigators hypothesize
that active case detection using the next generation of HRP-2 rapid diagnostic tests (RDTs)
can help bridge gaps in identification of high-risk asymptomatic individuals with low density
parasitemia, allowing for targeting of this reservoir and thereby reducing transmission. The
investigators hypothesize that active case detection (testing and treating positive cases)
with these RDTs will lead to a reduction in P. falciparum transmission.
Phase:
Phase 4
Details
Lead Sponsor:
University of California, San Francisco
Collaborators:
Center for Malariology, Parasitology, and Entomology Health Poverty Action The National Institute of Public Health
Treatments:
Artemether Artemether-lumefantrine combination Artemether, Lumefantrine Drug Combination Artemisinins Lumefantrine Primaquine